U-Blot® Research Grade Anti-Human CD200R1/OX2R Antibody (23ME-00610)Cat. No. WA1408Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD200R1/OX2R Antibody (23ME-00610)Cat. No. WA1408
U-Blot® Research Grade Anti-Human CD200 (TTI-CD200)Cat. No. WA1407
U-Blot® Research Grade Anti-Human CD20/MS4A1 Antibody (KM3575)Cat. No. WA1406
U-Blot® Research Grade Anti-Human CD20/MS4A1 (Zitux)Cat. No. WA1405
U-Blot® Research Grade Anti-Human CD20/MS4A1 (UB-923)Cat. No. WA1404
U-Blot® Research Grade Anti-Human CD20/MS4A1 (TRU015)Cat. No. WA1403
U-Blot® Research Grade Anti-Human CD20/MS4A1 (SM09)Cat. No. WA1402
U-Blot® Research Grade Anti-Human CD20/MS4A1 (PRO131921)Cat. No. WA1401
U-Blot® Research Grade Anti-Human CD20/MS4A1 (NAV006)Cat. No. WA1400
U-Blot® Research Grade Anti-Human CD20/MS4A1 (MT-3724)Cat. No. WA1399
U-Blot® Research Grade Anti-Human CD20/MS4A1 (MEDI-552)Cat. No. WA1398
U-Blot® Research Grade Anti-Human CD20/MS4A1 (mAb 1.5.3)Cat. No. WA1397